Ahrens Investment Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$79.5K Buy
+1,900
New +$79.9K 0.04% 252
2022
Q3
Sell
-19,850
Closed -$842K 250
2022
Q2
$842K Buy
19,850
+8,650
+77% +$376K 0.37% 61
2022
Q1
$510K Sell
11,200
-18,700
-63% -$829K 0.16% 100
2021
Q4
$1.45M Sell
29,900
-11,925
-29% -$565K 0.64% 34
2021
Q3
$1.99M Sell
41,825
-2,550
-6% -$124K 0.95% 27
2021
Q2
$2.15M Sell
44,375
-2,050
-4% -$98K 0.99% 17
2021
Q1
$2.15M Sell
46,425
-28,400
-38% -$1.35M 1.08% 20
2020
Q4
$3.56M Buy
74,825
+54,175
+262% +$2.46M 1.91% 11
2020
Q3
$885K Buy
20,650
+300
+1% +$12.8K 0.59% 44
2020
Q2
$830K Buy
+20,350
New +$821K 0.51% 51

Other funds holding BME

Ahrens Investment Partners's BME Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in BlackRock Health Sciences Trust (BME) in Q1 2023: 1,900 shares worth $79.5K. The stake represents 0.04% of the portfolio and ranks #252 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in BME as recently as Q2 2022.

Ahrens Investment Partners first reported a position in BME in Q2 2020 and has held it in 10 quarters since. The position peaked at $3.56M in Q4 2020. 71 funds tracked by Wall St. Rank hold BME as of Q1 2023.

  • Ahrens Investment Partners held 1,900 shares of BlackRock Health Sciences Trust worth $79.5K as of Q1 2023.
  • BlackRock Health Sciences Trust was a new Ahrens Investment Partners position in Q1 2023.
  • BlackRock Health Sciences Trust made up 0.04% of Ahrens Investment Partners's portfolio in Q1 2023, its #252 holding.
  • Ahrens Investment Partners first reported a position in BlackRock Health Sciences Trust in Q2 2020 and has held it in 10 quarters since.
  • Ahrens Investment Partners's BlackRock Health Sciences Trust position peaked at $3.56M in Q4 2020.
  • 71 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.